Walton William G, Ahmad Saira, Little Michael S, Kim Christine S K, Tyrrell Jean, Lin Qiao, Di Y Peter, Tarran Robert, Redinbo Matthew R
Departments of Chemistry, Biochemistry, and Microbiology, University of North Carolina , 4350 Genome Sciences Building, Chapel Hill, North Carolina 27599-3290, United States.
Marsico Lung Institute, Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina , 7102 Marsico Hall, Chapel Hill, North Carolina 27599-7248, United States.
Biochemistry. 2016 May 31;55(21):2979-91. doi: 10.1021/acs.biochem.6b00271. Epub 2016 May 17.
SPLUNC1 is an abundantly secreted innate immune protein in the mammalian respiratory tract that exerts bacteriostatic and antibiofilm effects, binds to lipopolysaccharide (LPS), and acts as a fluid-spreading surfactant. Here, we unravel the structural elements essential for the surfactant and antimicrobial functions of human SPLUNC1 (short palate lung nasal epithelial clone 1). A unique α-helix (α4) that extends from the body of SPLUNC1 is required for the bacteriostatic, surfactant, and LPS binding activities of this protein. Indeed, we find that mutation of just four leucine residues within this helical motif to alanine is sufficient to significantly inhibit the fluid spreading abilities of SPLUNC1, as well as its bacteriostatic actions against Gram-negative pathogens Burkholderia cenocepacia and Pseudomonas aeruginosa. Conformational flexibility in the body of SPLUNC1 is also involved in the bacteriostatic, surfactant, and LPS binding functions of the protein as revealed by disulfide mutants introduced into SPLUNC1. In addition, SPLUNC1 exerts antibiofilm effects against Gram-negative bacteria, although α4 is not involved in this activity. Interestingly, though, the introduction of surface electrostatic mutations away from α4 based on the unique dolphin SPLUNC1 sequence, and confirmed by crystal structure, is shown to impart antibiofilm activity against Staphylococcus aureus, the first SPLUNC1-dependent effect against a Gram-positive bacterium reported to date. Together, these data pinpoint SPLUNC1 structural motifs required for the antimicrobial and surfactant actions of this protective human protein.
SPLUNC1是哺乳动物呼吸道中大量分泌的一种固有免疫蛋白,具有抑菌和抗生物膜作用,能与脂多糖(LPS)结合,并作为一种液体扩散表面活性剂发挥作用。在此,我们揭示了人SPLUNC1(短腭肺鼻上皮克隆1)的表面活性剂和抗菌功能所必需的结构元件。从SPLUNC1主体延伸出的一个独特的α螺旋(α4)是该蛋白抑菌、表面活性剂及LPS结合活性所必需的。事实上,我们发现仅将该螺旋基序内的四个亮氨酸残基突变为丙氨酸就足以显著抑制SPLUNC1的液体扩散能力及其对革兰氏阴性病原体洋葱伯克霍尔德菌和铜绿假单胞菌的抑菌作用。引入到SPLUNC1中的二硫键突变体表明,SPLUNC1主体的构象灵活性也参与了该蛋白的抑菌、表面活性剂及LPS结合功能。此外,SPLUNC1对革兰氏阴性菌具有抗生物膜作用,尽管α4不参与此活性。然而,有趣的是,基于独特的海豚SPLUNC1序列在远离α4的位置引入表面静电突变,并经晶体结构证实,结果显示其对金黄色葡萄球菌具有抗生物膜活性,这是迄今为止报道的首例SPLUNC1对革兰氏阳性菌的依赖性作用。总之,这些数据明确了这种保护性人类蛋白抗菌和表面活性剂作用所需的SPLUNC1结构基序。